Display options
Cite
Weiskirchen R, Tacke F. Liver fibrosis: Which mechanisms matter?. Clin Liver Dis (Hoboken). 2016;8(4):94-99doi: 10.1002/cld.581.
Weiskirchen, R., & Tacke, F. (2016). Liver fibrosis: Which mechanisms matter?. Clinical liver disease, 8(4), 94-99. https://doi.org/10.1002/cld.581
Weiskirchen, Ralf, and Tacke, Frank. "Liver fibrosis: Which mechanisms matter?." Clinical liver disease vol. 8,4 (2016): 94-99. doi: https://doi.org/10.1002/cld.581
Weiskirchen R, Tacke F. Liver fibrosis: Which mechanisms matter?. Clin Liver Dis (Hoboken). 2016 Oct 27;8(4):94-99. doi: 10.1002/cld.581. eCollection 2016 Oct. PMID: 31041072; PMCID: PMC6490207.
Copy Download .nbib Format: NLM
Share it on

Clin Liver Dis (Hoboken). 2016 Oct 27;8(4):94-99. doi: 10.1002/cld.581. eCollection 2016 Oct.

Liver fibrosis: Which mechanisms matter?.

Clinical liver disease

Ralf Weiskirchen, Frank Tacke

Affiliations

  1. Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry.
  2. Department of Medicine III University Hospital RWTH Aachen Aachen Germany.

PMID: 31041072 PMCID: PMC6490207 DOI: 10.1002/cld.581

[No abstract available.]

References

  1. Am J Pathol. 1951 Nov-Dec;27(6):951-89 - PubMed
  2. J Clin Invest. 2005 Jan;115(1):56-65 - PubMed
  3. J Cell Mol Med. 2006 Jan-Mar;10(1):76-99 - PubMed
  4. Fibrogenesis Tissue Repair. 2013 Oct 01;6(1):19 - PubMed
  5. Gut. 2015 May;64(5):830-41 - PubMed
  6. J Hepatol. 2015 Jul;63(1):237-64 - PubMed
  7. J Hepatol. 2015 Apr;62(1 Suppl):S15-24 - PubMed
  8. Gastroenterology. 2015 Aug;149(2):389-97.e10 - PubMed
  9. J Hepatol. 2015 Oct;63(4):1038-9 - PubMed
  10. Front Pharmacol. 2016 Jan 07;6:303 - PubMed
  11. J Hepatol. 2016 May;64(5):1137-1146 - PubMed
  12. Cell Mol Immunol. 2016 May;13(3):316-27 - PubMed
  13. Cell Stem Cell. 2016 Jun 2;18(6):797-808 - PubMed
  14. Gastroenterology. 2016 Jun;150(8):1811-1822.e4 - PubMed
  15. Dig Dis. 2016;34(4):410-22 - PubMed
  16. J Clin Pathol. 1978 May;31(5):395-414 - PubMed

Publication Types